FFA
VTYX

Farther Finance Advisors’s Ventyx Biosciences VTYX Stock Holding History

Farther Finance Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$311 – 5601
2025
Q3 		$311 Hold
100
– – ﹤0.01% 4634
2025
Q2 		$214 Hold
100
– – ﹤0.01% 4197
2025
Q1 		$107 Sell
100
-639
-86% -$1.1K ﹤0.01% 4059
2024
Q4 		$1.62K Hold
739
– – ﹤0.01% 3086
2024
Q3 		$1.61K Sell
739
-556
-43% -$1.28K ﹤0.01% 3072
2024
Q2 		$2.93K Buy
1,295
+570
+79% +$2.37K ﹤0.01% 2634
2024
Q1 		$4.05K Buy
725
+718
+10,257% +$3.28K ﹤0.01% 2163
2023
Q4 		$17 Buy
+7
New +$66 ﹤0.01% 3475

Other funds holding VTYX

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Farther Finance Advisors's VTYX Position: Q4 2025 in Review

Farther Finance Advisors sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 100 shares — an estimated $311 sold.

Farther Finance Advisors first reported a position in VTYX in Q4 2023 and held it in 8 quarters. The position peaked at $4.05K in Q1 2024. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

  • Farther Finance Advisors reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
  • Farther Finance Advisors sold 100 Ventyx Biosciences shares in Q4 2025, an estimated $311.
  • Farther Finance Advisors first reported a position in Ventyx Biosciences in Q4 2023 and held it in 8 quarters.
  • Farther Finance Advisors's Ventyx Biosciences position peaked at $4.05K in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Farther Finance Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.